Advisors to the Food and Drug Administration have recommended the FDA approve Pfizer's COVID-19 vaccine for children 5 to 11.
The advisory panel voted unanimously, saying the benefits outweigh the risks.
Last week, Pfizer said the vaccine showed almost 91 percent efficacy in a clinical trial.
Participants were given a dose one-third that given to kids 12 and up.
A final green light will open the door for some 28 million children to get vaccinated.
Inoculations may begin as soon as next week, once the FDA and the CDC make the final call.